Market Tracker

09/23 5:16pm ET

Heron Therapeutics Inc (NASDAQ:HRTX)

18.18
Delayed Data
As of Sep 23
 -0.22 / -1.20%
Today’s Change
15.22
Today|||52-Week Range
40.94
-31.91%
Year-to-Date
No recent news for Heron Therapeutics Inc.

Today’s Trading

Previous close18.40
Today’s open18.30
Day’s range17.72 - 18.46
Volume638,059
Average volume (3 months)633,328
Market cap$709.9M
Dividend yield--
Data as of 3:59pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)-2.79%
Earnings growth (this year)-50.21%
Earnings growth (next 5 years)+70.57%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book5.56

Competitors

 Today’s
change
Today’s
% change
CORTCorcept Therapeutics...0.000.00%
AIMTAimmune Therapeutics...-0.39-2.30%
INOInovio Pharmaceutica...-0.24-2.46%
VNDAVanda Pharmaceutical...+0.19+1.14%
Data as of 3:59pm ET, 09/23/2016

Financials

Next reporting dateNovember 8, 2016
EPS forecast (this quarter)-$1.20
Annual revenue (last year)$0.00
Annual profit (last year)-$97.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Barry D. Quart
President, Director &
Chief Commercial Officer
Robert H. Rosen
Corporate headquarters
Redwood City, California

Forecasts